The Neural and Behavioral Correlates of How Donepezil Modulates Memory and Inhibitory Efficiency in the Context of 24 Hours of Sleep Deprivation.

Trial Profile

The Neural and Behavioral Correlates of How Donepezil Modulates Memory and Inhibitory Efficiency in the Context of 24 Hours of Sleep Deprivation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2016

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease; Attention deficit and disruptive behaviour disorders; Dementia; Migraine; Vascular dementia
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 06 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top